【创新药重磅消息! “T细胞黑马”Nektar(NKTR.US)湿疹疗效炸裂 股价单日暴涨150%】智通财经APP获悉,

智通财经
Jun 25, 2025
【创新药重磅消息! “T细胞黑马”Nektar(NKTR.US)湿疹疗效炸裂 股价单日暴涨150%】智通财经APP获悉,在周二美股交易时间段,全球创新药领域传来一则重磅消息,推动Nektar Therapeutics(NKTR.US)股价在美股盘中一度暴涨超180%,截至当日美股收盘收涨156%至24.450美元。此前这家资金吃紧的生物科技公司重磅公布,其用于治疗中重度特应性皮炎(也被称作湿疹)的药物 Rezpegaldesleukin在REZOLVE-AD 2b 期临床研究中取得超预期的积极结果,达到主要和次要终点,验证了公司以新型调节性T细胞治疗炎症性皮肤疾病的全新思路。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10